Stay updated with breaking news from Microdoz Therapy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
VANCOUVER, BC / ACCESSWIRE / December 14, 2022 / LOVE Pharma Co. ("LOVE" and or "The Company") (CSE:LUV)(FSE:G1Q0), the Company today announced a strategic move to sell its wholly owned subsidiary Microdoz
Dr. Albert Garcia Romeu will serve as head researcher for the Love Pharma's MicroDoz sponsored trial to be conducted at the Johns Hopkins Center for Psychedelic and Consciousness ResearchThe MicroDoz Therapy
On the legislative front of the psychedelics space, a new bill meant to study the therapeutic effects of psychedelic substances received fu...
4.05pm: Nasdaq drops 1.6% US stocks ended in the red Thursday as investors monitored the latest developments in the Ukraine-Russia conflict as well as the...
4.05pm: Nasdaq drops 1.6% US stocks ended in the red Thursday as investors monitored the latest developments in the Ukraine-Russia conflict as well as the...